China Health Industries Holdings, Inc.
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a CHHE research report →
Companywww.chinahealthindustries.com
China Health Industries Holdings, Inc. , through its subsidiaries, manufactures and sells health products. It offers hemp derivative products, such as hemp oil, hemp protein powder, hemp polypeptides, collagen peptides, hemp essence repair lotions, hemp revitalizing essence products, hemp anti-aging brightening eye creams, and hemp frozen age nourishing creams.
- CEO
- Sun Xin
- IPO
- 2009
- Employees
- 32
- HQ
- Harbin, CN
Price Chart
Valuation
- Market Cap
- $6.55K
- P/E
- -0.02
- P/S
- 0.06
- P/B
- 0.00
- EV/EBITDA
- -4.42
- Div Yield
- 0.00%
Profitability
- Gross Margin
- 0.20%
- Op Margin
- -1651.74%
- Net Margin
- -366.56%
- ROE
- -1.00%
- ROIC
- -4.16%
Growth & Income
- Revenue
- $111.58K · 41689.89%
- Net Income
- $-409,000 · -15.54%
- EPS
- $-0.01 · -14.81%
- Op Income
- $-1,843,000
- FCF YoY
- -2098.01%
Performance & Tape
- 52W High
- $0.22
- 52W Low
- $0.00
- 50D MA
- $0.00
- 200D MA
- $0.05
- Beta
- -20.54
- Avg Volume
- 557.456
Get TickerSpark's AI analysis on CHHE
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Recent Insider Transactions
| Date | Insider | Type | Shares |
|---|---|---|---|
| Mar 30, 15 | Xin Sun | other | 3,000,000 |
| Aug 21, 13 | Xin Sun | sell | 15,495,900 |
| Apr 7, 09 | Xin Sun | sell | 28,200,000 |
| Dec 31, 08 | Xin Sun | other | 60,000,000 |
| Sep 10, 07 | Xin Sun | other | 0 |
| Jul 25, 05 | Foster Teri S | other | 0 |
| Aug 26, 05 | EWING HALL E | other | 0 |
| Jul 25, 05 | Hahn Brian Lee | other | 0 |
| Aug 16, 05 | Robinson Jack C | other | 0 |
| May 10, 05 | Bontems Thomas Allen | other | 0 |
Our CHHE Coverage
We haven't published any research on CHHE yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate CHHE Report →